Concepedia

Publication | Open Access

Combination MEK and mTOR inhibitor therapy is active in models of glioblastoma

DOIFull Paper Access

37

Citations

37

References

2020

Year

Karisa C. Schreck, Amy N. Allen, Jiawan Wang, Christine A. Pratilas
Neuro-Oncology Advances

Abstract

These data demonstrate that combined MEK/mTOR inhibition is synergistic in glioblastoma cell lines and may be more potent in NF1-deficient glioblastoma.

References

YearCitations

Page 1